New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - olsalazine sodium 250mg - capsule - 250 mg - active: olsalazine sodium 250mg excipient: gelatin magnesium stearate opacode black s-1-17822 opacode black s-1-17823 - maintenance of patients with ulcerative colitis in remission. treatment of acute ulcerative colitis of mild to moderate severity with or without the concomitant use of steroids.

United States - English - NLM (National Library of Medicine)

meda pharmaceuticals inc. - olsalazine sodium (unii: y7jew0xg7i) (olsalazine - unii:uls5i8j03o) - olsalazine sodium 250 mg - dipentum is indicated for the maintenance of remission of ulcerative colitis in adult patients who are intolerant of sulfasalazine. dipentum is contraindicated in patients with known or suspected hypersensitivity to salicylates, aminosalicylates or their metabolites, or to any of the excipients in dipentum.

United States - English - NLM (National Library of Medicine)

carilion materials management - olsalazine sodium (unii: y7jew0xg7i) (olsalazine - unii:uls5i8j03o) - olsalazine sodium 250 mg - olsalazine is indicated for the maintenance of remission of ulcerative colitis in patients who are intolerant of sulfasalazine. hypersensitivity to olsalazine, other salicylates, or any of the excipients. none reported. drug dependence has not been reported with chronic administration of olsalazine.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ucb pharma ltd - olsalazine sodium - oral capsule - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - olsalazine sodium - oral capsule - 250mg

United States - English - NLM (National Library of Medicine)

carilion materials management - olsalazine sodium (unii: y7jew0xg7i) (olsalazine - unii:uls5i8j03o) - olsalazine sodium 250 mg - indications and usage: olsalazine is indicated for the maintenance of remission of ulcerative colitis in patients who are intolerant of sulfasalazine. contraindications: hypersensitivity to olsalazine, other salicylates, or any of the excipients. drug abuse and dependency: abuse: none reported. dependence: drug dependence has not been reported with chronic administration of olsalazine.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - olsalazine sodium - oral capsule - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - olsalazine sodium - oral capsule - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - olsalazine sodium - oral capsule - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

atnahs pharma uk ltd - olsalazine sodium - oral capsule - 250mg